White label – Pompe disease - ClinicalTrials.eu

Testing SAR442970 compared to placebo in adults with moderate to severe Crohn’s disease

Recruiting

2 1
Investigated Drugs:
- Sar442970
Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

Recruiting

3 1 1 1
Investigated Diseases:
- Neovascular age-related macular degeneration
- Age-related macular degeneration
Investigated Drugs:
- Ranibizumab
+3
Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer’s Disease over 72 weeks

Recruiting

2 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- VHB937
+2
Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Recruiting

4 1 1 1
Investigated Diseases:
- Transitional cell carcinoma
Investigated Drugs:
+5
Study of Atomoxetine to Reduce Freezing of Gait in Patients with Parkinson’s Disease During OFF-State

Recruiting

3 1 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Atomoxetine
Study of visugromab and nivolumab with or without docetaxel as second-line treatment for patients with metastatic non-squamous non-small cell lung cancer

Recruiting

2 1 1
Investigated Drugs:
Long-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder

Recruiting

3 1 1
Evaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression

Recruiting

3 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
+7
Early Treatment with Argipressin (Arginine Vasopressin) in Adult Intensive Care Patients with Norepinephrine-Resistant Vasoplegic Shock

Recruiting

3 1 1
Investigated Diseases:
- Vasoplegia syndrome
Investigated Drugs:
- Argipressin
- Sodium Chloride
Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Recruiting

3 1
Investigated Diseases:
- Arteriosclerosis
Investigated Drugs:
- Maridebart Cafraglutide
+12

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies